Vyome Therapeutics Inc CEO Venkat Nelabhotla sat down with Proactive Investors at the BIO CEO & Investor Conference in New York.
Vyome Therapeutics is a clinical stage speciality pharmaceutical company, with platform technologies and a pipeline of drugs for antibiotic-resistant acne and other skin pathogens.
The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...
FOR OUR FULL DISCLAIMER CLICK HERE
Director Interviews
The North American Marijuana Index, which tracks the top cannabis stocks in the US and Canada, lifted 1.7% higher at 111.3 points. Elsewhere, the Horizons Marijuana Life Sciences Index ETF grew 1.8% to C$9.13, while the OTCQX Cannabis index rose 1.3% to 432.3 points. Buds today are Canopy...
Director Interviews
Full interview: Singh Biotechnology's low-cost virtual company...
Basic Materials
Industry & services
Industry & services
Prev article
